Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
05/02/2002 | WO2001089450A3 Treating musculoskeletal disorders using lp85 and analogs thereof |
05/02/2002 | WO2001077137A9 Albumin fusion proteins |
05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
05/02/2002 | WO2001064749A3 Method for preparing anti-mif antibodies |
05/02/2002 | WO2001055210A3 Human cyr61 |
05/02/2002 | WO2001052829A3 Statin-type bone growth stimulators |
05/02/2002 | WO2001044264A3 Novel stromelysin inhibitors |
05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
05/02/2002 | US20020052527 Novel process for preparing alendronic acid |
05/02/2002 | US20020052513 Oxamide IMPDH inhibitors |
05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
05/02/2002 | US20020052504 N-((2-cyclopropoxy-5-(1H-tetrazol-1-))phenyl)methyl-2-(4 -phenyl)piperidin-3-amine and derivatives; in particular as neurokinin-1 receptor antagonists; analgesics; migraines; antiinflammatory, anxiolytic, emetic agents; antidepressants |
05/02/2002 | US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis |
05/02/2002 | US20020052409 Compounds and methods for treating mitochondria-associated diseases |
05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
05/02/2002 | US20020052387 5-Substituted 2-aryl-4-pyrimidinones |
05/02/2002 | US20020052386 Pyrimidine derivatives |
05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
05/02/2002 | US20020052369 Indolinone derivatives as protein kinase/phosphatase inhibitors |
05/02/2002 | US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis |
05/02/2002 | US20020052356 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
05/02/2002 | US20020052350 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses |
05/02/2002 | US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
05/02/2002 | US20020052323 Protease inhibitors, particularly for caspase enzyme; treating arthritis, ALS, MS, and the like. |
05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
05/02/2002 | US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof |
05/02/2002 | US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders |
05/02/2002 | US20020051822 Enhancing bone formation, inhibiting osteoclastic differentiation or activating osteoblastic differentialation by administering to a human or animal suffering from, or susceptible to bone disease a lanthanum compound |
05/02/2002 | US20020051771 Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders |
05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
05/02/2002 | EP1201639A2 Lipoxin compounds and their use in treating cell proliferative disorders |
05/02/2002 | EP1201241A2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
05/02/2002 | EP1201237A1 Composition comprising an amide or a dialkylsulphoxide derivative for the treatment of cancer |
05/02/2002 | EP1201231A2 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
05/02/2002 | EP1200596A2 Human synthetases |
05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
05/02/2002 | EP1200593A2 The il-1l1 gene and polypeptide products |
05/02/2002 | EP1200587A2 Receptors and associated proteins |
05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
05/02/2002 | EP1200570A1 Antisense modulation of p13 kinase p110 delta expression |
05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
05/02/2002 | EP1200555A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
05/02/2002 | EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
05/02/2002 | EP1200457A2 Cysteine protease inhibitors |
05/02/2002 | EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders |
05/02/2002 | EP1200438A2 Method for making debromohymenialdisine and analogs thereof |
05/02/2002 | EP1200432A1 Amido spiropiperidines promote the release of growth hormone |
05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
05/02/2002 | EP1200399A1 Vitamin d3 analogs |
05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
05/02/2002 | EP1200127A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
05/02/2002 | EP1200106A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
05/02/2002 | EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
05/02/2002 | EP1200076A1 Calcilytic compounds |
05/02/2002 | EP0931086B1 Tetrahydronaphthalene derivatives and their therapeutic use |
05/02/2002 | DE10052658A1 Neue Pyranosidderivate New Pyranosidderivate |
05/02/2002 | DE10052333A1 Neue Sulfooxybenzamide New Sulfooxybenzamide |
05/02/2002 | DE10049549A1 Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40 |
05/02/2002 | CA2678256A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
05/02/2002 | CA2427085A1 Transmembrane proteins |
05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
05/02/2002 | CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis |
05/02/2002 | CA2426564A1 Pyranoside derivatives |
05/02/2002 | CA2426463A1 Novel aggrecanase molecules |
05/02/2002 | CA2426244A1 Lipid formulations for target delivery |
05/02/2002 | CA2426007A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
05/02/2002 | CA2421885A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
05/02/2002 | CA2420164A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
05/01/2002 | CN1347420A Growth hormone secretagogues |
05/01/2002 | CN1347411A Sulfonamide derivs. having oxadiazole rings |
05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
05/01/2002 | CN1347323A Chemical compounds |
05/01/2002 | CN1347322A Chemical compounds |
05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
05/01/2002 | CN1346673A Chinese patent medicine for treating hyperosteogeny |
05/01/2002 | CN1346670A Medicine for treating hyperosteogeny |
05/01/2002 | CN1346661A Medicine for setting up bone |
05/01/2002 | CN1346655A Liquid medicine for treating traumatic injury |
05/01/2002 | CN1346647A Quick-acting antalgic plaster for detumescence and detoxication |
05/01/2002 | CN1346644A Oral Chinese medicine for treating bone fracture |
05/01/2002 | CN1083722C Plaster for treating hyperosteogeny and protrusion of lumbar vertebral disc |
04/30/2002 | US6380396 Chemical intermediates for antiinflammatory agents |
04/30/2002 | US6380374 Isolated nucleic acid; culture product |
04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
04/30/2002 | US6380251 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
04/30/2002 | US6380250 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |